Literature DB >> 10448805

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

Z Guo1, L Fratiglioni, L Zhu, J Fastbom, B Winblad, M Viitanen.   

Abstract

OBJECTIVE: To examine whether antihypertensive medication use can affect the occurrence and progression of dementia. SUBJECTS AND METHODS: In a community cohort of 1810 persons aged 75 years and older, 225 prevalent cases of dementia were detected. Among the 1301 persons without dementia, 224 incident cases of dementia were identified during an average period of 3 years. Among the 225 prevalent cases of dementia, 79 were suitable for the analysis of cognitive decline. Information on drug use was collected for the 2 weeks preceding the baseline interview.
RESULTS: Subjects taking antihypertensive medication (n = 651, 83.9% of whom took diuretics) had a lower prevalence of dementia than those not taking antihypertensive medication (P<.001). Subjects without dementia who were taking antihypertensive medication at baseline (n = 584) had a reduced incidence of dementia (adjusted relative risk, 0.7; 95% confidence interval, 0.6-1.0; P = .03). Furthermore, subjects taking diuretics (n = 484) had an adjusted relative risk of 0.7 (95% confidence interval, 0.5-1.0; P = .02) for all dementia, and subjects taking diuretic monotherapy (n = 345) had an adjusted relative risk of 0.6 (95% confidence interval, 0.4-0.9; P = .006). The use of other antihypertensive medication (calcium antagonists or beta-blockers), however, was related to a reduced risk of Alzheimer disease (adjusted relative risk, 0.6; 95% confidence interval, 0.3-1.2) only in the subpopulation with a higher baseline blood pressure (n = 458). Patients with dementia at baseline who were not taking diuretics had a 2-fold faster rate of decline in the score on the Mini-Mental State Examination than those taking diuretics.
CONCLUSION: The use of diuretics may protect against dementia in elderly persons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448805     DOI: 10.1001/archneur.56.8.991

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  48 in total

Review 1.  Hypertension and dementia.

Authors:  A S Rigaud; O Hanon; M L Seux; F Forette
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 2.  Does the angiotensin II receptor antagonist losartan improve cognitive function?

Authors:  Michele A Tedesco; Gennaro Ratti; Giovanni Di Salvo; Francesco Natale
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

4.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

5.  A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Maria Nunes; Astrid Fletcher; Françoise Forette; Christopher Bulpitt
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Analysis of substance use and its outcomes by machine learning: II. Derivation and prediction of the trajectory of substance use severity.

Authors:  Ziheng Hu; Yankang Jing; Ying Xue; Peihao Fan; Lirong Wang; Michael Vanyukov; Levent Kirisci; Junmei Wang; Ralph E Tarter; Xiang-Qun Xie
Journal:  Drug Alcohol Depend       Date:  2019-10-01       Impact factor: 4.492

Review 7.  Vascular risk factors: imaging and neuropathologic correlates.

Authors:  David S Knopman; Rosebud Roberts
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.

Authors:  Jessica B S Langbaum; Kewei Chen; Lenore J Launer; Adam S Fleisher; Wendy Lee; Xiaofen Liu; Hillary D Protas; Stephanie A Reeder; Daniel Bandy; Meixiang Yu; Richard J Caselli; Eric M Reiman
Journal:  Neurobiol Aging       Date:  2011-08-06       Impact factor: 4.673

9.  Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR after tMCAO.

Authors:  Tomoko Kurata; Violeta Lukic; Miki Kozuki; Daisuke Wada; Kazunori Miyazaki; Nobutoshi Morimoto; Yasuyuki Ohta; Kentaro Deguchi; Toru Yamashita; Nozomi Hishikawa; Kosuke Matsuzono; Yoshio Ikeda; Tatsushi Kamiya; Koji Abe
Journal:  Transl Stroke Res       Date:  2014-01-17       Impact factor: 6.829

Review 10.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.